# SEVELAMER CARBONATE
> **ANDA211316** · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX · Approved 2020-11-20
## Drug
- **FDA Application Number:** ANDA211316
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SEVELAMER CARBONATE
- **Generic name:** SEVELAMER CARBONATE
- **Active ingredients:** SEVELAMER CARBONATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IMPAX
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 2020-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211316)
---
*AI Analytics · CC0 1.0*